Antipyrine and caffeine dispositions in clinically normal dogs and dogs with progressive liver disease
- PMID: 8172417
Antipyrine and caffeine dispositions in clinically normal dogs and dogs with progressive liver disease
Abstract
Dispositions of caffeine and antipyrine were compared as indicators of decreasing hepatic function in dogs with experimentally induced progressive liver disease. Dimethylnitrosamine, a hepatospecific toxin, was administered orally to 16 dogs; 6 dogs served as controls (group 1). Three classes of liver disease were defined by histologic features: mild (group 2; n = 5), moderate (group 3; n = 6), and severe (group 4; n = 5). Disposition of antipyrine, and 24 hours later, caffeine was studied 3 weeks after the last dose of toxin in each dog. For both drugs, rapid IV administration of 20 mg/kg of body weight was administered and serum samples were obtained at intervals for determination of at least 5 terminal-phase drug half-lives. For both drugs, clearance and mean residence time differed among groups (P < or = 0.01). Clearance of antipyrine and caffeine was decreased in groups 3 and 4, compared with groups 1 and 2. Antipyrine and caffeine mean residence times were longer in group-3 dogs, compared with dogs of groups 1 and 2. Correction of caffeine and antipyrine clearances for hepatic weight increased discrimination between groups 3 and 4. The clearance and mean residence time ratios of antipyrine to caffeine were calculated for each group and, when compared with values for group-1 dogs, were used to test for differences between the 2 drugs in response to disease. Ratios did not differ among groups. These results indicate that the disposition of antipyrine and caffeine may change similarly with progression of dimethylnitrosamine-induced liver disease.
Similar articles
-
Indocyanine green disposition in healthy dogs and dogs with mild, moderate, or severe dimethylnitrosamine-induced hepatic disease.Am J Vet Res. 1992 Mar;53(3):382-8. Am J Vet Res. 1992. PMID: 1595965
-
Application of an enzyme-multiplied immunoassay technique for determination of caffeine elimination kinetics as a test of liver function in clinically normal dogs.Am J Vet Res. 1994 Jun;55(6):790-4. Am J Vet Res. 1994. PMID: 7944016
-
Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig.Xenobiotica. 1995 May;25(5):491-9. doi: 10.3109/00498259509061868. Xenobiotica. 1995. PMID: 7571722
-
Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites.Clin Pharmacokinet. 1991 Jan;20(1):50-65. doi: 10.2165/00003088-199120010-00004. Clin Pharmacokinet. 1991. PMID: 2029802 Review.
-
[The caffeine test].Therapie. 1989 Jul-Aug;44(4):245-51. Therapie. 1989. PMID: 2688184 Review. French.
Cited by
-
Preliminary studies of a canine 13C-aminopyrine demethylation blood test.Can J Vet Res. 2001 Jan;65(1):45-9. Can J Vet Res. 2001. PMID: 11227194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical